The Saint John’s Cancer Institute is dedicated to developing innovative breakthrough diagnostics and treatments for cancer in order to eliminate patient suffering and prolong survival. Below are a list of select issued US patents on technologies developed at our institution.
Use of long noncoding RNA as a biomarker and therapeutic marker in cancer
Topical Drugs for the Treatment of Melanoma
Utility of B-RAF DNA mutation in diagnosis and treatment of cancer
Epigenetic silencing of cyclooxygenase-2 to predict clinical outcome in gastric cancer
Utility of RET mutant in diagnosis and treatment of melanoma
Molecular Lymphatic Mapping of Sentinel Lymph Nodes
Methods for Lymph Node Identification
Detection of micro-metastasis of melanoma in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR
Detection of cancer cells in body fluids
DNA markers for management of cancer
Use of ID4 for diagnosis and treatment of cancer
*This list does not include patents that have been licensed.